Jorge Conde

speaker

469 appearances 4 recordings 1 series first heard Sep 2025 last heard 2 Sep

Jorge Conde’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 2 in all, peaking in Sep 2026 with 1.

Appearances

newest first · ▶ plays the moment

The a16z Show · Faster Science, Better Drugs · 15 Sep 2025 podcast

Um and you know, it's it's interesting because, you know, we talk about, you know, uh all of the various stakeholders when you're making a a drug.

Uh there are the companies.

There's of course the science that supported um the the company that's trying to commercialize a uh a product, and there are the regulatory agencies.

You know, and everyone is trying to ensure again that uh what's you know, first and foremost is the ability to um uh discover and commercialize drugs that are safe and effective for humans.

That middle part part of actually getting through that bottleneck is hard to speed up.

in a very obvious way.

Like you can increase the rate the way you enroll clinical trials.

You can use better technology to change the way we design these clinical trials.

So maybe they can be faster or shorter, et cetera.

But some of them just have a natural timeline.

You have to go through.

Like if you want to demonstrate that a cancer drug uh promotes survival.

Guess what?

You're gonna have to it's gonna take some time to demonstrate a survival benefit.

Or if you know you want to do a longevity drug, that by definition is a lifetime, you know, uh of a of a trial in terms of length.

So there's a lot of these bottlenecks are really hard to get through.

So what helps the industry?

I think there are a couple of things that uh help the industry.

One is um capital intensity.

uh will hopefully at some point go down over time as technology gets better.

Showing 341–360 of 469 · page 18 of 24